CPD: Multi-Modality Approaches for Managing GLP/GIP Side Effects
Aesthetic nurse prescriber Anna Baker discusses multi-modality approaches to addressing tissue changes with glucagon-like peptide-1 agonists and glucose-dependent insulinotropic polypeptide therapies Current literature suggests that medical aesthetic practitioners are noticing an increase in demand from patients seeking treatments to counteract …
To access this post, you must purchase Aesthetics Journal Membership – Annual Elite Membership or Aesthetics Journal Membership – Annual Enhanced Membership.
